[9] [14] For any GLP-1 patch to gain clinical acceptance, it would need to demonstrate non-inferior efficacy to these established benchmarks through head-to-head comparative trials
Factors like adherence, diet, exercise, sleep, stress, and genetics all influence outcomes
Plaintiffs further allege that Hims promoted the product through website, television, and social media advertisements that referenced the same active ingredient as Ozempic and Wegovy and highlighted partnerships with FDA-regulated pharmacies
This suggests that retatrutide does not just reduce energy intake (calories in) but actively increases energy output (calories out), a dual-modality influence that tirzepatide does not theoretically possess to the same degree
What was the early development failure of cagrilintide, and how was it overcome
Annals Clin Biochemistry: Int J Lab Med